The CHA2DS2-VASc score and Geriatric Multidimensional Assessment tools in elderly patients with persistent atrial fibrillation undergoing electrical cardioversion. A link with arrhythmia relapse?

被引:6
|
作者
Fumagalli, Stefano [1 ,2 ,3 ]
Pelagalli, Giulia [1 ,2 ,3 ]
Montorzi, Riccardo Franci [1 ,2 ,3 ]
Marozzi, Irene [1 ,2 ,3 ]
Migliorini, Marta [1 ,2 ,3 ]
D'Andria, Maria Flora [1 ,2 ,3 ]
Lip, Gregory Y. H. [4 ,5 ,6 ]
Marchionni, Niccolo [1 ,2 ,3 ]
机构
[1] Univ Florence, Geriatr Intens Care Unit, Largo Brambilla 3, I-50134 Florence, Italy
[2] Univ Florence, Geriatr Arrhythmia Unit, Largo Brambilla 3, I-50134 Florence, Italy
[3] AOU Careggi, Largo Brambilla 3, I-50134 Florence, Italy
[4] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England
[5] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England
[6] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark
关键词
Atrial fibrillation; CHA(2)DS(2)-VASc; Elderly; Geriatric Depression Scale; Mini-Mental State Examination; Short Physical Performance Battery; LOWER-EXTREMITY FUNCTION; RISK STRATIFICATION; MORTALITY; AGE; ASSOCIATION; MANAGEMENT; FAILURE; FRAILTY; STROKE; RHYTHM;
D O I
10.1016/j.ejim.2020.07.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The CHA(2)DS(2)-VASc score is widely used for stroke risk stratification in patients with atrial fibrillation (AF). Our endpoints were to evaluate in an old population undergoing electrical cardioversion (ECV) of persistent AF if the CHA(2)DS(2)-VASc was associated with some of the Geriatric Multidimensional Assessment tools and with the presence of sinus rhythm at the follow-up. Methods: We enrolled all the consecutive patients admitted in a day-hospital setting aged >= 60 years. The Mini-Mental State Examination (MMSE; neurocognitive function), the 15-item Geriatric Depression Scale (GDS; depressive symptoms) and the Short Physical Performance Battery (SPPB; physical functioning) were administered before ECV. Results: Between 2017 and 2019, 134 patients were enrolled (mean age: 77 +/- 9 years, range: 60-96; men: 63.4%; EF: 60 +/- 12%). Hypertension was the most frequent comorbid condition (82.1%). The CHA(2)DS(2)-VASc score was 3.8 +/- 1.6. Abnormal values of MMSE, GDS and SPPB were observed in 7.9, 19.8 and 22.3% of cases, respectively. There were significant correlations between the CHA(2)DS(2)-VASc score and the MMSE (p = 0.008), the GDS (p < 0.001) and the SPPB (p < 0.001). Depressive symptoms increased CHA(2)DS(2)-VASc correlation with SPPB of about 20%. CHA(2)DS(2)-VASc score was higher in patients with arrhythmia relapse (p = 0.048; mean length of follow-up: 195 days). This association persisted even after adjustment for amiodarone therapy. Conclusions: The CHA(2)DS(2)-VASc score significantly correlated with neuro-cognitive performance, depressive symptoms and physical functioning. It was also associated with AF relapse. Accordingly, in the elderly, the CHA(2)DS(2)-VASc could help quantify thrombo-embolic risk, give an indication of frailty status and help to choose between a rate- and a rhythm-control strategy.
引用
收藏
页码:56 / 61
页数:6
相关论文
共 50 条
  • [1] CHA2DS2-VASc score as a predictor of long-term cardiac outcomes in elderly patients with or without atrial fibrillation
    Xing, Yunli
    Sun, Ying
    Li, Hongwei
    Tang, Mei
    Huang, Wei
    Zhang, Kan
    Zhang, Dai
    Zhang, Deqiang
    Ma, Qing
    CLINICAL INTERVENTIONS IN AGING, 2018, 13 : 497 - 504
  • [2] CHA2DS2-VASc in the prediction of early atrial fibrillation relapses after electrical or pharmacological cardioversion
    Falsetti, Lorenzo
    Viticchi, Giovanna
    Tarquinio, Nicola
    Silvestrini, Mauro
    Capeci, William
    Balloni, Andrea
    Catozzo, Vania
    Gentile, Adelina
    Pellegrini, Francesco
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2014, 15 (08) : 636 - 641
  • [3] The role of CHA2DS2-VASc score in evaluating patients with atrial fibrillation undergoing percutaneous coronary intervention
    Parfrey, Shane
    Teh, Andrew W.
    Roberts, Louise
    Brennan, Angela
    Clark, David
    Duffy, Stephen J.
    Ajani, Andrew E.
    Reid, Christopher M.
    Freeman, Melanie
    CORONARY ARTERY DISEASE, 2021, 32 (04) : 288 - 294
  • [4] CHA2DS2-VASc score and fibrinogen concentration in patients with atrial fibrillation
    Semczuk-Kaczmarek, Karolina
    Platek, Anna E.
    Rys, Anna
    Adamowicz, Jakub
    Legosz, Pawel
    Kotkowski, Marcin
    Dudzik-Plocica, Alicja
    Gorko, Dariusz
    Szymanski, Filip M.
    Filipiak, Krzysztof J.
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 28 (11): : 1451 - 1457
  • [5] Stroke Risk in Atrial Fibrillation: Beyond the CHA2DS2-VASc Score
    Jagadish, Pooja S.
    Kabra, Rajesh
    CURRENT CARDIOLOGY REPORTS, 2019, 21 (09)
  • [6] CHA2DS2-VASc score as a prognostic indicator in patients with atrial fibrillation undergoing coronary stenting
    Zheng, Jian-Yong
    Li, Dong-Tao
    Qiu, Yi-Gang
    Huang, Yi-Xiong
    Xu, Zheng-Ming
    Zhao, Li
    Chen, Yu
    Cao, Yi
    Tang, Yi-Da
    Guo, Cheng-Jun
    Ma, Zhi-Min
    Wu, Yong-Quan
    Jiao, Yan
    Li, Tian-Chang
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (04) : 1103 - 1110
  • [7] CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation
    Saliba, Walid
    Rennert, Gad
    AMERICAN JOURNAL OF MEDICINE, 2014, 127 (01) : 45 - 52
  • [8] CHA2DS2VASc score predicts unsuccessful electrical cardioversion in patients with persistent atrial fibrillation
    Mlodawska, Elzbieta
    Tomaszuk-Kazberuk, Anna
    Lopatowska, Paulina
    Kaminski, Marcin
    Musial, Wlodzimierz J.
    INTERNAL MEDICINE JOURNAL, 2017, 47 (03) : 275 - 279
  • [9] CHA2DS2-VASc score and prognosis in ischemic strokes with atrial fibrillation
    Giralt-Steinhauer, Eva
    Cuadrado-Godia, Elisa
    Ois, Angel
    Jimenez-Conde, Jordi
    Rodriguez-Campello, Ana
    Planellas, Lluis
    Jimena-Garcia, Sara
    Angel Rubio, Miguel
    Roquer-Gonzalez, Jaume
    JOURNAL OF NEUROLOGY, 2012, 259 (04) : 745 - 751
  • [10] Assessment of the CHA2DS2-VASc Score for the Prediction of Death in Elderly Patients With Coronary Artery Disease and Atrial Fibrillation
    Wu, Yangxun
    Wang, Guanyun
    Dong, Lisha
    Qin, Liu'an
    Li, Jian
    Yan, Hengming
    Guo, Wenjie
    Feng, Xiaodong
    Zou, Yuting
    Wang, Ziqian
    Du, Rina
    Zhang, Yuxiao
    Ma, Jing
    Yin, Tong
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8